« BackUrologic Oncology: Seminars and Original Investigations
Article in Press

Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma

  • Grégory Verhoest, M.D.

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
    • Department of Urology, Rennes University Hospital, Rennes, France
    • Corresponding Author InformationCorresponding author. Tel.+33 2 99 28 96 96; fax:+33 2 99 28 41 13.
  • ,
  • Jean-Jacques Patard, M.D., Ph.D.

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
    • Department of Urology, Rennes University Hospital, Rennes, France
  • ,
  • Patricia Fergelot, M.D.

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
    • Department of Biochemistry, Rennes University Hospital, Rennes, France
  • ,
  • Florence Jouan

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
  • ,
  • Salim Zerrouki, M.D.

      Affiliations

    • Department of Biochemistry, Rennes University Hospital, Rennes, France
  • ,
  • Stéphane Dreano

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
  • ,
  • Stéphanie Mottier

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
  • ,
  • Nathalie Rioux-Leclercq, M.D., Ph.D.

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
    • Department of Pathology, Rennes University Hospital, Rennes, France
  • ,
  • Marc G. Denis, M.D., Ph.D.

      Affiliations

    • CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France
    • Department of Biochemistry, Rennes University Hospital, Rennes, France

Received 15 February 2010; received in revised form 25 May 2010; accepted 13 July 2010. published online 28 September 2010.
Corrected Proof

Abstract 

Introduction:

Literature controversies exist regarding the prognostic value of VHL mutations. The objective was to compare paraffin-embedded and frozen section specimens for VHL mutations detection and to evaluate the reliability of DNA analysis in formalin-fixed tissues.

Methods:

Seventy-six patients with clear cell renal cell carcinoma (RCC) previously assessed for VHL status from frozen samples were included. Seventy-three tumor samples were known to be mutated for VHL. DNA was extracted and an electrophoresis was performed to determine DNA quality. The whole coding sequence was synthesized by double PCR amplification followed by sequencing. Sequencing results were compared with those previously determined from frozen samples.

Results:

DNA could be extracted from the 76 paraffin samples. DNA quality was highly degraded and significantly less amplified by PCR in 34.2%, resulting in no sequence available for analysis in 57.7% and discordance with frozen samples in 42.3% of the cases respectively. VHL mutations were found in 52.1% of the whole paraffin samples whereas 98% were mutated; 72% could be sequenced, resulting in 69.1% of VHL mutations in this subset. Only half of observed mutations were fully consistent with frozen analysis in the 3 exons. Neomutations were found in 10.5% and 28.9% of known mutations in frozen samples were not detected in paraffin blocks. Only DNA quality significantly influenced PCR amplification and sequencing.

Conclusion:

Tumoral DNA extraction and VHL mutation analysis can be performed from formalin-fixed paraffin-embedded (FFPE) tissue in RCC. But mutations identified tissues are not strictly concordant with those from frozen analysis and therefore results obtained from FFPE samples should be interpreted with care.

Keywords: VHL gene, Renal cell carcinoma, Paraffin, VEGF, Angiogenesis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(10)00179-1

doi:10.1016/j.urolonc.2010.07.005

« BackUrologic Oncology: Seminars and Original Investigations